Research Use Cases: Cohort & Subject-Level Analysis
Neurodiagnoses supports cohort-level statistical discovery and structured subject-level multimodal profiling using the same unified mathematical and biological framework.
Analytical Workflows
Two complementary research modes operating over the same underlying computational models.
Cohort-Level Analysis (Data Lab)
Open Research Tool
Designed for cohort datasets (n = 20–500+) to validate multi-omic causal relationships, perform cross-sectional distributions, and examine subgroup biomarker progression.
Capabilities
- Cohort-wide causal validation scores across biological axes
- Parametric and non-parametric comparative statistics
- Multi-modal scatter distributions and correlation matrices
- Direct tabular data export formatted for publication
Subject-Level Profiling (Case Analyzer)
Structured Analysis Pipeline
Standardized multi-step ingestion protocol to structure genetic variants, fluid biomarkers, and volumetric neuroimaging data for an individual subject in a research cohort.
Capabilities
- 5-step structured data entry adhering to standardized templates
- Individual causal validation concordance index
- Region-specific volumetric atrophy concordance assessment
- Comprehensive computation log suitable for clinical trial archives
Algorithmic Consistency Between Workflows
Both the cohort analysis engine and the individual case analyzer utilize identical statistical kernels. Numerical results obtained in the web platform match reference computational scripts exactly (unpublished manuscript, not peer-reviewed).
Aggregated variance across subjects determines causal pathway significance thresholds.
Individual observations are scored against calibrated normative references without ad-hoc alterations.
Research Vignettes
Multimodal Concordance in Asymptomatic Carriers
Investigating whether APOE ε4 dosage associates with early elevations in plasma p-tau217 before detectable volumetric loss in medial temporal structures across 140 research participants.
Trial Participant Biomarker Verification
Verifying complete multi-axis eligibility for a candidate participant: confirming pathogenic status, fluid biomarker positivity (Aβ42/40 ratio < threshold), and quantitative hippocampal volume percentile.